1. Home
  2. MDV vs KRRO Comparison

MDV vs KRRO Comparison

Compare MDV & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$17.93

Market Cap

159.4M

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.16

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
KRRO
Founded
2015
2014
Country
United States
United States
Employees
12
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.4M
150.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MDV
KRRO
Price
$17.93
$13.16
Analyst Decision
Strong Buy
Buy
Analyst Count
2
12
Target Price
$18.00
$34.80
AVG Volume (30 Days)
42.4K
110.5K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
7.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$13.80
$5.20
52 Week High
$16.43
$55.89

Technical Indicators

Market Signals
Indicator
MDV
KRRO
Relative Strength Index (RSI) 82.07 51.35
Support Level $14.09 $10.81
Resistance Level N/A $14.76
Average True Range (ATR) 0.32 0.74
MACD 0.13 -0.11
Stochastic Oscillator 95.15 34.51

Price Performance

Historical Comparison
MDV
KRRO

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: